254 related articles for article (PubMed ID: 34831411)
1. Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy.
Schierova D; Roubalova R; Kolar M; Stehlikova Z; Rob F; Jackova Z; Coufal S; Thon T; Mihula M; Modrak M; Kverka M; Bajer L; Kostovcikova K; Drastich P; Hercogova J; Novakova M; Vasatko M; Lukas M; Tlaskalova-Hogenova H; Jiraskova Zakostelska Z
Cells; 2021 Nov; 10(11):. PubMed ID: 34831411
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
[TBL] [Abstract][Full Text] [Related]
3. Attributes of intestinal microbiota composition and their correlation with clinical primary non-response to anti-TNF-α agents in inflammatory bowel disease patients.
Alatawi H; Mosli M; Saadah OI; Annese V; Al-Hindi R; Alatawy M; Al-Amrah H; Alshehri D; Bahieldin A; Edris S
Bosn J Basic Med Sci; 2022 Jun; 22(3):412-426. PubMed ID: 34761733
[TBL] [Abstract][Full Text] [Related]
4. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
[TBL] [Abstract][Full Text] [Related]
5. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
8. The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis.
Carstens A; Dicksved J; Nelson R; Lindqvist M; Andreasson A; Bohr J; Tysk C; Talley NJ; Agréus L; Engstrand L; Halfvarson J
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00065. PubMed ID: 31343467
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: A comprehensive systematic review.
Wang C; Gu Y; Chu Q; Wang X; Ding Y; Qin X; Liu T; Wang S; Liu X; Wang B; Cao H
Microbiol Res; 2024 May; 282():127660. PubMed ID: 38442454
[TBL] [Abstract][Full Text] [Related]
10. The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.
Alexander JL; Mullish BH; Danckert NP; Liu Z; Olbei ML; Saifuddin A; Torkizadeh M; Ibraheim H; Blanco JM; Roberts LA; Bewshea CM; Nice R; Lin S; Prabhudev H; Sands C; Horneffer-van der Sluis V; Lewis M; Sebastian S; Lees CW; Teare JP; Hart A; Goodhand JR; Kennedy NA; Korcsmaros T; Marchesi JR; Ahmad T; Powell N
EBioMedicine; 2023 Feb; 88():104430. PubMed ID: 36634565
[TBL] [Abstract][Full Text] [Related]
11. Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.
Chehoud C; Albenberg LG; Judge C; Hoffmann C; Grunberg S; Bittinger K; Baldassano RN; Lewis JD; Bushman FD; Wu GD
Inflamm Bowel Dis; 2015 Aug; 21(8):1948-56. PubMed ID: 26083617
[TBL] [Abstract][Full Text] [Related]
12. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
13. The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease.
Malham M; Lilje B; Houen G; Winther K; Andersen PS; Jakobsen C
Scand J Gastroenterol; 2019 Aug; 54(8):969-975. PubMed ID: 31329473
[No Abstract] [Full Text] [Related]
14. Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease.
Ventin-Holmberg R; Eberl A; Saqib S; Korpela K; Virtanen S; Sipponen T; Salonen A; Saavalainen P; Nissilä E
J Crohns Colitis; 2021 Jun; 15(6):1019-1031. PubMed ID: 33300552
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
Forbes JD; Chen CY; Knox NC; Marrie RA; El-Gabalawy H; de Kievit T; Alfa M; Bernstein CN; Van Domselaar G
Microbiome; 2018 Dec; 6(1):221. PubMed ID: 30545401
[TBL] [Abstract][Full Text] [Related]
16. Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean.
Rausch P; Ellul S; Pisani A; Bang C; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
Inflamm Bowel Dis; 2023 Jul; 29(7):1118-1132. PubMed ID: 36735955
[TBL] [Abstract][Full Text] [Related]
17. 16S sequencing and functional analysis of the fecal microbiome during treatment of newly diagnosed pediatric inflammatory bowel disease.
Ashton JJ; Colquhoun CM; Cleary DW; Coelho T; Haggarty R; Mulder I; Batra A; Afzal NA; Beattie RM; Scott KP; Ennis S
Medicine (Baltimore); 2017 Jun; 96(26):e7347. PubMed ID: 28658154
[TBL] [Abstract][Full Text] [Related]
18. Seasonal variations in gut microbiota and disease course in patients with inflammatory bowel disease.
Tani M; Shinzaki S; Asakura A; Tashiro T; Amano T; Otake-Kasamoto Y; Yoshihara T; Yoshii S; Tsujii Y; Hayashi Y; Inoue T; Motooka D; Nakamura S; Iijima H; Takehara T
PLoS One; 2023; 18(4):e0283880. PubMed ID: 37071621
[TBL] [Abstract][Full Text] [Related]
19. Similar Gut Bacterial Composition Between Patients With Ulcerative Colitis and Healthy Controls in a High Incidence Population: A Cross-sectional Study of the Faroe Islands IBD Cohort.
Berbisá MÁF; Nielsen KR; Ingham AC; Midjord J; Hammer T; Patursson P; Vest NMO; Gregersen NO; Burisch J; Vang A
Inflamm Bowel Dis; 2022 Jul; 28(7):1081-1089. PubMed ID: 35138361
[TBL] [Abstract][Full Text] [Related]
20. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.
Imai T; Inoue R; Kawada Y; Morita Y; Inatomi O; Nishida A; Bamba S; Kawahara M; Andoh A
J Gastroenterol; 2019 Feb; 54(2):149-159. PubMed ID: 30478724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
